Patient Engagement in Clinical Trial Protocol Design and Recruitment Strategies: What Does It Mean for Orphan Drug Manufacturers?

Jul 15, 2019

Posted by Evidera, Inc.

Involving rare disease patients and their caregivers in drug development, and particularly protocol design and operational implementation planning, could provide myriad benefits to the trial sponsor and the target patient and caregiver community at large. Click here to read our recent white paper to understand the challenges and benefits of engaging patients in orphan and rare disease clinical trial protocol design, how to elicit patient input, and how to improve the patient experience.

To learn more about our patient-centered research services, visit our website or contact us.

See all Member News